TLR4 is an LPS receptor and elevation of LPS in most animal models of NAFLD causes hepatic steatosis, hepatic insulin resistance, and increased liver weight, making TLR4-LPS the key pathway promoting the development of NAFLD [176]. The gene discussed is TLR4; the disease is Hepatic steatosis.